80. Mahmoudi M, Bertrand N, Zope H, Farokhzad OC (2016) Emerging understanding of
the protein corona at the nano-bio interfaces.
Nano Today 11:817–832
81. Safavi-Sohi R, Maghari S, Raoufi M, Jalali SA,
Hajipour MJ, Ghassempour A, Mahmoudi M
(2016) Bypassing protein corona issue on
active targeting: zwitterionic coatings dictate
specific interactions of targeting moieties and
cell receptors. ACS Appl Mater Interfaces
8:22808–22818
82. Monopoli MP, Walczyk D, Campbell A,
Elia G, Lynch I, Baldelli Bombelli F, Dawson
KA (2011) PhysicalÀchemical aspects of protein corona: relevance to in vitro and in vivo
biological impacts of nanoparticles. J Am
Chem Soc 133:2525–2534
83. Tenzer S, Docter D, Kuharev J,
Musyanovych A, Fetz V, Hecht R, Schlenk F,
Fischer D, Kiouptsi K, Reinhardt C,
Landfester K, Schild H, Maskos M, Knauer
SK, Stauber RH (2013) Rapid formation of
plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol
8:772–781
84. Koh WL, Tham PH, Yu H, Leo HL, Yong
Kah JC (2016) Aggregation and protein
corona formation on gold nanoparticles affect
viability and liver functions of primary rat
hepatocytes.
Nanomedicine
(Lond)
11:2275–2287
85. Walkey CD, Chan WCW (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological
environment. Chem Soc Rev 41:2780–2799
86. Lundqvist M, Stigler J, Cedervall T,
Bergga ˚rd T, Flanagan MB, Lynch I, Elia G,
Dawson K (2011) The evolution of the protein corona around nanoparticles: a test study.
ACS Nano 5:7503–7509
87. Tenzer S, Docter D, Rosfa S, Wlodarski A,
Kuharev J, Rekik A, Knauer SK, Bantz C,
Nawroth T, Bier C, Sirirattanapan J,
Mann W, Treuel L, Zellner R, Maskos M,
Schild H, Stauber RH (2011) Nanoparticle
size is a critical physicochemical determinant
of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS
Nano 5:7155–7167
88. Laurent S, Ng EP, Thirifays C, Lakiss L, Goupil GM, Mintova S, Burtea C, Oveisi E,
He ´bert C, De Vries M, Motazacker MM,
Rezaee F, Mahmoudi M (2013) Corona protein composition and cytotoxicity evaluation
of ultra-small zeolites synthesized from template free precursor suspensions. Toxicol Res
(Camb) 2:270–279
89. Mahmoudi M, Monopoli MP, Rezaei M,
Lynch I, Bertoli F, Mcmanus JJ, Dawson KA
(2013) The protein corona mediates the
impact of nanomaterials and slows amyloid
beta fibrillation. Chembiochem 14:568–572
90. Lundqvist M, Stigler J, Elia G, Lynch I,
Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the
protein corona with possible implications for
biological impacts. Proc Natl Acad Sci U S A
105:14265–14270
91. Ehrenberg MS, Friedman AE, Finkelstein JN,
Oberdo ¨rster G, McGrath JL (2009) The
influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Biomaterials 30:603–610
92. Caracciolo G, Callipo L, De Sanctis SC,
Cavaliere C, Pozzi D, Lagana ` A (2010) Surface adsorption of protein corona controls the
cell internalization mechanism of DC-CholDOPE/DNA lipoplexes in serum. Biochim
Biophys Acta Biomembr 1798:536–543
93. Docter D, Bantz C, Westmeier D, Galla HJ,
Wang Q, Kirkpatrick JC, Nielsen P,
Maskos M, Stauber RH (2014) The protein
corona protects against size- and dosedependent toxicity of amorphous silica nanoparticles.
Beilstein
J
Nanotechnol
5:1380–1392
94. Mahmoudi M, Laurent S, Shokrgozar MA,
Hosseinkhani M (2011) Toxicity evaluations
of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical
properties of nanoparticles. ACS Nano
5:7263–7276
95. Mahmoudi M, Saeedi-Eslami SN, Shokrgozar
MA, Azadmanesh K, Hassanlou M, Kalhor
HR, Burtea C, Rothen-Rutishauser B,
Laurent S, Sheibani S, Vali H (2012) Cell
“vision”: complementary factor of protein
corona in nanotoxicology. Nanoscale
4:5461–5468
96. Zhang H, Burnum KE, Luna ML, Petritis
BO, Kim JS, Qian WJ, Moore RJ, HerediaLangner A, Webb-Robertson BJM, Thrall
BD, Camp DG, Smith RD, Pounds JG, Liu
T (2011) Quantitative proteomics analysis of
adsorbed plasma proteins classifies nanoparticles with different surface properties and size.
Proteomics 11:4569–4577
97. Caracciolo G, Pozzi D, Capriotti AL,
Cavaliere C, Foglia P, Amenitsch H, Lagana `
A (2011) Evolution of the protein corona of
lipid gene vectors as a function of plasma concentration. Langmuir 27:15048–15053
98. Laurent S, Burtea C, Thirifays C, Rezaee F,
Mahmoudi M (2013) Significance of cell
“observer” and protein source in nanobiosciences. J Colloid Interface Sci 392:431–445
99. Caracciolo G, Pozzi D, Capriotti AL,
Cavaliere C, Piovesana S, La Barbera G,
SWATH-MS Protocols in Human Diseases
139
the protein corona at the nano-bio interfaces.
Nano Today 11:817–832
81. Safavi-Sohi R, Maghari S, Raoufi M, Jalali SA,
Hajipour MJ, Ghassempour A, Mahmoudi M
(2016) Bypassing protein corona issue on
active targeting: zwitterionic coatings dictate
specific interactions of targeting moieties and
cell receptors. ACS Appl Mater Interfaces
8:22808–22818
82. Monopoli MP, Walczyk D, Campbell A,
Elia G, Lynch I, Baldelli Bombelli F, Dawson
KA (2011) PhysicalÀchemical aspects of protein corona: relevance to in vitro and in vivo
biological impacts of nanoparticles. J Am
Chem Soc 133:2525–2534
83. Tenzer S, Docter D, Kuharev J,
Musyanovych A, Fetz V, Hecht R, Schlenk F,
Fischer D, Kiouptsi K, Reinhardt C,
Landfester K, Schild H, Maskos M, Knauer
SK, Stauber RH (2013) Rapid formation of
plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol
8:772–781
84. Koh WL, Tham PH, Yu H, Leo HL, Yong
Kah JC (2016) Aggregation and protein
corona formation on gold nanoparticles affect
viability and liver functions of primary rat
hepatocytes.
Nanomedicine
(Lond)
11:2275–2287
85. Walkey CD, Chan WCW (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological
environment. Chem Soc Rev 41:2780–2799
86. Lundqvist M, Stigler J, Cedervall T,
Bergga ˚rd T, Flanagan MB, Lynch I, Elia G,
Dawson K (2011) The evolution of the protein corona around nanoparticles: a test study.
ACS Nano 5:7503–7509
87. Tenzer S, Docter D, Rosfa S, Wlodarski A,
Kuharev J, Rekik A, Knauer SK, Bantz C,
Nawroth T, Bier C, Sirirattanapan J,
Mann W, Treuel L, Zellner R, Maskos M,
Schild H, Stauber RH (2011) Nanoparticle
size is a critical physicochemical determinant
of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS
Nano 5:7155–7167
88. Laurent S, Ng EP, Thirifays C, Lakiss L, Goupil GM, Mintova S, Burtea C, Oveisi E,
He ´bert C, De Vries M, Motazacker MM,
Rezaee F, Mahmoudi M (2013) Corona protein composition and cytotoxicity evaluation
of ultra-small zeolites synthesized from template free precursor suspensions. Toxicol Res
(Camb) 2:270–279
89. Mahmoudi M, Monopoli MP, Rezaei M,
Lynch I, Bertoli F, Mcmanus JJ, Dawson KA
(2013) The protein corona mediates the
impact of nanomaterials and slows amyloid
beta fibrillation. Chembiochem 14:568–572
90. Lundqvist M, Stigler J, Elia G, Lynch I,
Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the
protein corona with possible implications for
biological impacts. Proc Natl Acad Sci U S A
105:14265–14270
91. Ehrenberg MS, Friedman AE, Finkelstein JN,
Oberdo ¨rster G, McGrath JL (2009) The
influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Biomaterials 30:603–610
92. Caracciolo G, Callipo L, De Sanctis SC,
Cavaliere C, Pozzi D, Lagana ` A (2010) Surface adsorption of protein corona controls the
cell internalization mechanism of DC-CholDOPE/DNA lipoplexes in serum. Biochim
Biophys Acta Biomembr 1798:536–543
93. Docter D, Bantz C, Westmeier D, Galla HJ,
Wang Q, Kirkpatrick JC, Nielsen P,
Maskos M, Stauber RH (2014) The protein
corona protects against size- and dosedependent toxicity of amorphous silica nanoparticles.
Beilstein
J
Nanotechnol
5:1380–1392
94. Mahmoudi M, Laurent S, Shokrgozar MA,
Hosseinkhani M (2011) Toxicity evaluations
of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical
properties of nanoparticles. ACS Nano
5:7263–7276
95. Mahmoudi M, Saeedi-Eslami SN, Shokrgozar
MA, Azadmanesh K, Hassanlou M, Kalhor
HR, Burtea C, Rothen-Rutishauser B,
Laurent S, Sheibani S, Vali H (2012) Cell
“vision”: complementary factor of protein
corona in nanotoxicology. Nanoscale
4:5461–5468
96. Zhang H, Burnum KE, Luna ML, Petritis
BO, Kim JS, Qian WJ, Moore RJ, HerediaLangner A, Webb-Robertson BJM, Thrall
BD, Camp DG, Smith RD, Pounds JG, Liu
T (2011) Quantitative proteomics analysis of
adsorbed plasma proteins classifies nanoparticles with different surface properties and size.
Proteomics 11:4569–4577
97. Caracciolo G, Pozzi D, Capriotti AL,
Cavaliere C, Foglia P, Amenitsch H, Lagana `
A (2011) Evolution of the protein corona of
lipid gene vectors as a function of plasma concentration. Langmuir 27:15048–15053
98. Laurent S, Burtea C, Thirifays C, Rezaee F,
Mahmoudi M (2013) Significance of cell
“observer” and protein source in nanobiosciences. J Colloid Interface Sci 392:431–445
99. Caracciolo G, Pozzi D, Capriotti AL,
Cavaliere C, Piovesana S, La Barbera G,
SWATH-MS Protocols in Human Diseases
139